Xiaoli Ma
Impact in
-
- Antibiotic Use and Resistance
-
- Microbial Natural Products and Biosynthesis
- Musculoskeletal pain and rehabilitation
Papers in
-
- Natural product bioactivities and synthesis 5
- Plant biochemistry and biosynthesis 4
- Ubiquitin and proteasome pathways 3
- S100 Proteins and Annexins 2
- Oncology 6
- Co-authors
- Songlin Yu (15 shared papers)Ling Qiu (13 shared papers)Yutong Zou (12 shared papers)Nicol Korner‐Bitensky (1 shared paper)Maureen J. Simmonds (1 shared paper)Shahnaz Shahrbanian (1 shared paper)Danchen Wang (7 shared papers)Qiuling Tang (2 shared papers)
In The Last Decade
Xiaoli Ma
33 papers receiving 309 citations
Peers
Comparison fields: 5 of 93
- Applied Microbiology and Biotechnology 20
- Pharmacology 44
- Clinical Biochemistry 15
- Molecular Biology 150
- Molecular Medicine 10
Countries citing papers authored by Xiaoli Ma
This map shows the geographic impact of Xiaoli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Ma more than expected).
Fields of papers citing papers by Xiaoli Ma
This network shows the impact of papers produced by Xiaoli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Ma. The network helps show where Xiaoli Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 31 | |
| 2 | 2009 | 30 | |
| 3 | 2018 | 23 | |
| 4 | 2009 | 23 | |
| 5 | 2024 | 20 | |
| 6 | 2022 | 15 | |
| 7 | 2023 | 15 | |
| 8 | 2020 | 13 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 13 | |
| 11 | 2015 | 12 | |
| 12 | 2022 | 12 | |
| 13 | 2010 | 11 | |
| 14 | 2008 | 11 | |
| 15 | 2023 | 8 | |
| 16 | 2024 | 8 | |
| 17 | 2024 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2021 | 6 | |
| 20 | 2014 | 5 |
About Xiaoli Ma
Xiaoli Ma is a scholar working on Molecular Biology, Oncology, Physiology, Pharmacology and Surgery, having authored 33 papers that have together received 315 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (5 papers), Plant biochemistry and biosynthesis (4 papers), Alzheimer's disease research and treatments (3 papers), Ubiquitin and proteasome pathways (3 papers), Microbial Natural Products and Biosynthesis (2 papers), Dementia and Cognitive Impairment Research (2 papers), S100 Proteins and Annexins (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (20 citations), Pharmacology (44 citations), Clinical Biochemistry (15 citations), Molecular Biology (150 citations) and Molecular Medicine (10 citations). Xiaoli Ma has collaborated with scholars based in China, Canada and Ireland. Frequent co-authors include Songlin Yu, Ling Qiu, Yutong Zou, Nicol Korner‐Bitensky, Maureen J. Simmonds, Shahnaz Shahrbanian, Danchen Wang, Qiuling Tang, Lifang Liu and Xinqi Cheng. Their work appears in journals such as Journal of Chromatography A, Clinica Chimica Acta, Journal of Chromatography B, Clinical Cancer Research and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.